Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

01/08/2018 05:30

Aug 1 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             24.14               24.97            94.80    
                 (-3.3 pct)          (-4.8 pct)       (-3.7 pct)  
  Operating          5.65                7.65            22.50    
                 (-26.2 pct)         (-5.5 pct)       (-18.2 pct) 
  Recurring          5.82                7.81            22.80    
                 (-25.6 pct)         (-4.9 pct)       (-18.1 pct) 
  Net                4.04                5.46            16.40    
                 (-26.1 pct)         (-5.7 pct)       (-13.9 pct) 
  EPS            100.16 yen          133.81 yen       411.18 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div                             75.00 yen        75.00 yen  
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T